Jan De Witte - Jan 18, 2024 Form 4 Insider Report for INTEGRA LIFESCIENCES HOLDINGS CORP (IART)

Role: President & CEO, Director
Signature: /s/ Eric Schwartz; Attorney-in-Fact
Stock symbol: IART
Transactions as of: Jan 18, 2024
Transactions value $: -$25,307
Form type: 4
Date filed: 1/19/2024, 04:43 PM
Previous filing: Nov 20, 2023
Next filing: Mar 12, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	IART	Common Stock	Options Exercise	$0	+597	+3.25%	$0.00	18.9K	Jan 18, 2024	Direct
transaction	IART	Common Stock	Tax liability	-$25.3K	-597	-3.15%	$42.39	18.4K	Jan 18, 2024	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	IART	Restricted Stock Units	Options Exercise	$0	-597	-0.66%	$0.00	89.4K	Jan 18, 2024	Common Stock	597	$0.00	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The award was a restricted stock unit award which vests in three annual equal installments on the first, second and third anniversaries of the grant date of 1/18/2022 of which the second installment vested on 1/18/2024 and which shall be delivered to Mr. De Witte within 30 days following the first business day that occurs immediately following the six-month period after the date of his separation of service as deferred compensation.

Content

The award was a restricted stock unit award which vests in three annual equal installments on the first, second and third anniversaries of the grant date of 1/18/2022 of which the second installment vested on 1/18/2024 and which shall be delivered to Mr. De Witte within 30 days following the first business day that occurs immediately following the six-month period after the date of his separation of service as deferred compensation.